Is Esperion Therapeutics Worth $130? This Analyst Thinks So
March 27, 2015 at 18:17 PM EDT
In a report published Friday, Citi analysts initiated coverage Esperion Therapeutics Inc (NASDAQ: ESPR) with a Buy rating and a price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.